The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/66764FDF.svg?ark=w1%2F20260515%2F66764FDF)](https://nobleid.org/work/w1/20260515/66764FDF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors